Oct 2026· Neurology International· 0 citations· 52 references
TL;DR
The findings suggest that the hybrid multimodal fusion model provides a promising computer-aided approach for three-class classification of AD, MCI, and NC.
Abstract
Background: Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder where early diagnosis at the mild cognitive impairment (MCI) stage is critical for timely intervention. While structural MRI (sMRI) and resting-state functional MRI (rs-fMRI) provide complementary pathological information, clinical translation is limited by high feature heterogeneity and the heavy computational burden of 3D deep learning networks. This study aims to propose a lightweight, hybrid multimodal fusion model to overcome these limitations and improve diagnostic efficiency. Methods: A lightweight MobileViT-XS network was utilized to extract global and local pathological features from gray-matter sMRI images to reduce computational costs. Concurrently, graph theory was applied to rs-fMRI data to construct brain functional networks and calculate global topological properties. Following pretraining, feature-level fusion was performed to integrate sMRI features, rs-fMRI properties, demographic information, and two clinical neuropsychological examinations. Results: The validation results show that the proposed hybrid model achieved high diagnostic performance in the three-class classification task, yielding an accuracy of 0.928 ± 0.010, sensitivity of 0.901 ± 0.014, precision of 0.933 ± 0.014, and an F1 score of 0.911 ± 0.012. On the held-out testing subset of the independently collected dataset after dataset-specific fine-tuning, the proposed model achieved an accuracy of 0.857, with a sensitivity of 0.867, a precision of 0.867, and an F1 score of 0.859. Conclusions: The proposed framework successfully minimizes computational overhead while maintaining high classification accuracy. These findings suggest that the hybrid multimodal fusion model provides a promising computer-aided approach for three-class classification of AD, MCI, and NC.
An advanced DL-powered framework for the early prediction of AD using MRI data demonstrates high accuracy, robustness, and interpretability, supporting its potential for reliable early AD diagnosis in clinical settings.
K. V. S. V. Trinadh Reddy, Gundeboyina Srinivasalu, T. V. Rao et al.· Archives of Medical Research· 0 citations
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with an increasingly common
prevalence all around the world, necessitating the development of an early, accurate, and minimally
invasive diagnosis method for such a devastating condition. However, traditional diagnostic methods
such as neuropsychologic...
Ratnakala Patil, Sachinkumar Veerashetty· Archives for Technical Scien...· 0 citations
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline. Identifying the condition at an early stage is essential for timely intervention and diagnosis. To improve MRI-based four-class AD classification, this study employs ResNeXt50 with Label Smoothing (LS) for four-clas...
Meng-Yan Xia· International Journal of Bio...· 0 citations
Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, affecting millions globally. As populations continue to age, AD prevalence is expected to rise significantly, placing substantial burdens on healthcare systems. Early detection of cognitive decline is essential, as interv...
Samaneh Rezaeimanesh, Mohammad Fili, Gui-Ping Hu et al.· IISE Annual Conference &...· 0 citations
Results demonstrate the effectiveness of the preprocessing strategy and its potential as a non-invasive biomarker for early PD detection, even with reduced input data, and suggest that high classification performance can be achieved with a limited number of fMRI slices, facilitating data acquisition and reducing subjec...
Veronica Hernandez-Ramirez, D. Almanza-Ojeda, Oscar Almanza-Conejo et al.· Technologies· 0 citations